About: Freenome, Inc., a biotechnology company, develops blood-based screening tests to detect cancer in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer. It develops SimpleScreen" CRC, a blood-based test, including a test for colorectal cancer screening, as well as tests for multi-cancer and multi-disease detection, such as lung, breast, cervical, liver, pancreatic, and esophageal cancers. The company was founded in 2014 and is headquartered in Brisbane, California.
Sector: Healthcare
Industry: Diagnostics & Research
Latest price: $17.11 (+5.03%)
FRNM NASDAQ Freenome, Inc. Common stock
Freenome, Inc. Common stock share price
FRNM price activity
Last Price
$16.620
Change (24hr)
-0.49 USD (-2.86%)
Volume
475.77K
Volume (4w avg)
-
Open
$17.19
Day Range
$16.62 - $17.48
Previous Close
$17.11
Last Trade
21 Sep, 7:59 pm GMT+0
Delayed
21 Sep, 7:59 pm GMT+0
FRNM price performance
Delayed
21 Sep, 7:59 pm GMT+0
FRNM Market Signals